Andy Whitney, Phd Email & Phone Number
@appliedmt.com
LinkedIn matched
Who is Andy Whitney, Phd? Overview
A concise factual answer block for searchers comparing this professional profile.
Andy Whitney, Phd is listed as Chief Scientific Officer at Ensho Therapeutics at Ensho Therapeutics, based in Mercer Island, Washington, United States. AeroLeads shows a work email signal at appliedmt.com and a matched LinkedIn profile for Andy Whitney, Phd.
Andy Whitney, Phd previously worked as Chief Scientific Officer at Ensho Therapeutics and Principal at Choucas Consulting Llc. Andy Whitney, Phd holds Phd, Cell Biology from Yale School Of Medicine.
Email format at Ensho Therapeutics
This section adds company-level context without repeating Andy Whitney, Phd's masked contact details.
AeroLeads found 1 current-domain work email signal for Andy Whitney, Phd. Compare company email patterns before reaching out.
About Andy Whitney, Phd
I’m an experienced scientific leader with a passion for translating scientific knowledge into therapeutics to help people live better lives. With an emphasis on building strong internal pipelines for autoimmune/inflammatory disease, oncology, metabolic and rare diseases I have had the opportunity to take multiple drug discovery projects and companies through successful business milestones (INDs, acquisitions, IPOs, and approvals).
Listed skills include Drug Discovery, Oncology, Cell Biology, Biotechnology, and 24 others.
Andy Whitney, Phd's current company
Company context helps verify the profile and gives searchers a useful next step.
Andy Whitney, Phd work experience
A career timeline built from the work history available for this profile.
Principal
CurrentPreclinical and translational advisory and consulting services for biopharmaceutical companies
Svp, Research And Translational Science
- Led AMT’s research and translational efforts to develop novel oral and inhaled biologic therapeutics for autoimmune and inflammatory and metabolic diseases.
- Built-out company capabilities in discovery research, preclinical development, pharmacodynamic biomarkers/translational sciences.
- Championed portfolio development and new programs; project leader for oral IL-22 program through preclinical testing and through successful (CTA) regulatory filing
Vp, Preclinical Development And Translational Science
Vice President Biology In Residence
Led nonclinical biology efforts for multiple BridgeBio subsidiaries focused on developing medicines for patients with genetically driven diseases.
Director, Biology
Strategic leader in Gilead’s inflammation and oncology research; evaluated new inflammation and oncology targets and enhanced research and innovations through internal team leadership and collaborations.Project lead/lead biologist on multiple small molecule drug discovery projects in inflammation & oncology; including novel target for Inflammatory Bowel.
Director, Structural Chemistry
Senior Director/Project Leader, Inflammation And Autoimmune Disease
Project Leader on pivotal pre-clinical program targeting Spleen Tyrosine Kinase (Syk) for autoimmune and oncological diseases; central to $120M acquisition of CGI by Gilead Sciences.
Senior Director, Biology And Informatics
Department head for biology and bioinformatics groupsKey member of R&D Leadership Team that built CGI from technology-based start-up into a fully integrated drug discovery company developing small molecule kinase inhibitors for oncology and autoimmune/inflammatory disease.Core member on multiple target validation and drug discovery projects (e.g. Btk) in.
Director/Principal Scientist/Senior Scientist, Research Informatics
Instrumental in development of CGI’s research strategy and application of technology-based scientific programs, including establishing and managing biology, bioinformatics, and cheminformatics capabilities.
Andy Whitney, Phd education
Phd, Cell Biology
A.B.
Frequently asked questions about Andy Whitney, Phd
Quick answers generated from the profile data available on this page.
What company does Andy Whitney, Phd work for?
Andy Whitney, Phd works for Ensho Therapeutics.
What is Andy Whitney, Phd's role at Ensho Therapeutics?
Andy Whitney, Phd is listed as Chief Scientific Officer at Ensho Therapeutics at Ensho Therapeutics.
What is Andy Whitney, Phd's email address?
AeroLeads has found 1 work email signal at @appliedmt.com for Andy Whitney, Phd at Ensho Therapeutics.
Where is Andy Whitney, Phd based?
Andy Whitney, Phd is based in Mercer Island, Washington, United States while working with Ensho Therapeutics.
What companies has Andy Whitney, Phd worked for?
Andy Whitney, Phd has worked for Ensho Therapeutics, Choucas Consulting Llc, Applied Molecular Transport, Bridgebio, and Gilead Sciences.
How can I contact Andy Whitney, Phd?
You can use AeroLeads to view verified contact signals for Andy Whitney, Phd at Ensho Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Andy Whitney, Phd attend?
Andy Whitney, Phd holds Phd, Cell Biology from Yale School Of Medicine.
What skills is Andy Whitney, Phd known for?
Andy Whitney, Phd is listed with skills including Drug Discovery, Oncology, Cell Biology, Biotechnology, Drug Development, Lifesciences, Pharmaceutical Industry, and Signal Transduction.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial